[HTML][HTML] 225Ac-PSMA-617 in chemotherapy-naive patients with advanced prostate cancer: a pilot study

M Sathekge, F Bruchertseifer, O Knoesen… - European journal of …, 2019 - Springer
Background A remarkable therapeutic efficacy has been demonstrated with 225 Ac-prostate-
specific membrane antigen (PSMA)-617 in heavily pre-treated metastatic castration-resistant …

Intraindividual comparison of 18F-PSMA-1007 and 18F-DCFPyL PET/CT in the prospective evaluation of patients with newly diagnosed prostate carcinoma: a pilot …

FL Giesel, L Will, I Lawal, T Lengana… - Journal of Nuclear …, 2018 - Soc Nuclear Med
The introduction of 18F-labeled prostate-specific membrane antigen (PSMA)–targeted
PET/CT tracers, first 18F-DCFPyL (2-(3-{1-carboxy-5-[(6-18F-fluoro-pyridine-3-carbonyl) …

Predictors of overall and disease-free survival in metastatic castration-resistant prostate cancer patients receiving 225Ac-PSMA-617 radioligand therapy

M Sathekge, F Bruchertseifer, M Vorster… - Journal of Nuclear …, 2020 - Soc Nuclear Med
Metastatic prostate carcinoma overexpresses prostate-specific membrane antigen (PSMA),
making this antigen a suitable target for radioligand therapy of the disease. Here we report …

18F-FDG-PET metabolic metrics and International Prognostic Score for risk assessment in HIV-infected patients with Hodgkin lymphoma

IO Lawal, AO Ankrah, GO Popoola… - Nuclear Medicine …, 2018 - journals.lww.com
Objectives Baseline metabolic metrics on fluorine-18-fluorodeoxyglucose PET (18 F-FDG
PET) have prognostic value in Hodgkin lymphoma. International Prognostic Score (IPS) is …

18F-FDG PET/CT in the detection of asymptomatic malignant melanoma recurrence

I Lawal, T Lengana, K Ololade… - Nuklearmedizin …, 2017 - thieme-connect.com
Aim: To evaluate the diagnostic accuracy of FDG PET/CT in the detection of asymptomatic
recurrence in patients with malignant melanoma who have had resection of their primary …

Correction to: 225Ac-PSMA-617 in chemotherapy-naive patients with advanced prostate cancer: a pilot study

M Sathekge, F Bruchertseifer, O Knoesen… - European Journal of …, 2019 - ncbi.nlm.nih.gov
Correction to: 225Ac-PSMA-617 in chemotherapy-naive patients with advanced prostate
cancer: a pilot study - PMC Back to Top Skip to main content NIH NLM Logo Access keys NCBI …

[HTML][HTML] Fluorodeoxyglucose Positron Emission Tomography integrated with computed tomography in carcinoma of the cervix: Its impact on accurate staging and the …

IO Lawal, T Lengana, C Janse van Rensburg… - PLoS …, 2019 - journals.plos.org
Objectives To determine the impact of FDG-PET/CT in the initial staging of cervical cancer
among women with and without HIV and to determine the abilities of FDG-PET/CT metabolic …

Use of a sentinel lymph node biopsy algorithm in a south African population of patients with cervical cancer and high prevalence of human immunodeficiency virus …

LC Snyman, EP Bryant, EI Wethmar… - International Journal of …, 2018 - ijgc.bmj.com
Objectives Cervical cancer is common in resource-poor settings with high prevalence of
tuberculosis, pelvic inflammatory disease, and human immunodeficiency virus (HIV) …

[PDF][PDF] Gallium-68-dotatate PET/CT is better than CT in the management of somatostatin expressing tumors: First experience in Africa

IO Lawal, KO Ololade, T Lengana, F Reyneke… - Hell J Nucl …, 2017 - academia.edu
Objectives: In this study we aimed to present our experience on the use of Gallium-68-
dotatate with posi-68 tron emission tomography, computed tomography (Ga-dotatate …

[HTML][HTML] Burkitt lymphoma and cavernous sinus syndrome with breast uptake on 18F-FDG-PET/CT: a case report

F Reyneke, N Mokgoro, M Vorster, M Sathekge - Medicine, 2017 - journals.lww.com
Interventions: She was started on chemotherapy with adjuvant radiotherapy. Outcomes: After
her first cycle of chemotherapy, repeat 18F-FDG PET/CT imaging revealed a marked …